The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation

The severe prognosis linked with a lung cancer diagnosis has changed with the discovery of oncogenic molecularly driven subgroups and the use of tailored treatment. ALK-translocated advanced lung cancer is the most interesting model, having achieved the longest overall survival. Here, we report the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bearz, Alessandra, De Carlo, Elisa, Del Conte, Alessandro, Spina, Michele, Da Ros, Valentina, Bertoli, Elisa, Revelant, Alberto, Stanzione, Brigida, Tirelli, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266866/
https://www.ncbi.nlm.nih.gov/pubmed/35806325
http://dx.doi.org/10.3390/ijms23137322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266866/
https://www.ncbi.nlm.nih.gov/pubmed/35806325
http://dx.doi.org/10.3390/ijms23137322

Ejemplares similares